GlassScriptPhysician profile
Timothy D Erickson
NPI 1447364724
$2,068.86
in general payments reported to CMS, 2019-2025
23 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.42 · 2022: $20.01 · 2024: $768 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $225.79 | 2024-2025 | Vyepti |
| Pfizer INC. | $217.08 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $184.96 | 2024-2025 | Ultomiris |
| Acadia Pharmaceuticals INC | $150.38 | 2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $149.14 | 2025 | Crexont |
| Lilly USA, LLC | $139.24 | 2024 | Kisunla, Reyvow, Emgality |
| Ucb, INC. | $135.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $115.08 | 2025 | Wainua |
| Livanova USA, INC. | $101.79 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $97.69 | 2025 | |
| Abbvie INC. | $80.09 | 2024-2025 | |
| Genentech, INC. | $73.22 | 2024 | Ocrevus |
| Neurelis, INC. | $62.18 | 2024-2025 | Valtoco |
| Genentech USA, INC. | $56.51 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Amgen INC. | $46.10 | 2024-2025 | Uplizna |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $39.29 | 2024 | Vyvgart Hytrulo, Vyvgart |
| Sk Life Science, INC. | $31.59 | 2024 | |
| Jazz Pharmaceuticals INC. | $31.26 | 2025 | |
| Ge Healthcare | $29.92 | 2025 | |
| Emd Serono, INC. | $29.59 | 2025 | |
| Janssen Scientific Affairs, LLC | $27.42 | 2021 | |
| Grifols USA, LLC | $25.53 | 2025 | Gamunex-C |
| Organon LLC | $20.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.